Image

A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes

Join a study for new glaucoma treatment testing.

Recruiting
18 years and older
All
Phase 1

Study Overview: This study is for people with chronic open-angle glaucoma or ocular hypertension in both eyes. Glaucoma is a condition that can damage the eye's optic nerve, and ocular hypertension means high pressure inside the eye. The study aims to compare the effects of two treatments on eye pressure (IOP).

Participants will be randomly assigned to one of two treatment groups. The study will last about 6 weeks, with check-ins at the 2-week and 6-week marks. Before starting the study, participants will need to stop using their current eye pressure medication for up to 4 weeks. The main goal is to see if there's a difference in eye pressure after using the study's treatments. Researchers will also monitor any side effects.

Key Points:

  • Study length: 6 weeks with visits at 2 weeks and 6 weeks.
  • No cost for participation, but stopping current medication is needed.
  • Risks include potential side effects; these will be monitored closely.

This study is important for understanding better treatment options for people with eye conditions. If interested, you must meet specific criteria and be 18 years or older. Pregnant women or those planning to become pregnant cannot participate.

Study details
    Open-angle Glaucoma
    Ocular Hypertension

NCT06267274

Amneal Pharmaceuticals, LLC

13 December 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.